Tenon Medical, Inc. (TNON)
TNONNASDAQ-CMMedical/Dental Instruments
$1.76
0.0000 (0.00%) today
Regular session, Nov 10, 3:43 PM ET
- Market cap
- $4.73m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $1.73 to $1.94
- 52-week range
- $1.57 to $45.50
- Average volume
- 6.66m
- Previous close
- $1.76
Analysts
1 coveringStrong Buy1 buy, 0 hold, 0 sell
Targets a year out average $10.00, +468.2% from here
Earnings
Next report Nov 12, 2026
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $1.17m | $1.48m | $1.38m | $1.28m |
| Gross profit | $773.0k | $1.02m | $945.0k | $814.0k |
| Operating income | -$3.39m | -$2.87m | -$3.28m | -$3.35m |
| Net income | -$3.34m | -$2.83m | -$3.48m | -$4.05m |
Last four quarters: revenue $5.31m, margin -257.9%, free cash flow -$12.07m
News
8 latest- Tenon Medical, Inc. Enters Waiver Agreement on October 16, 2026 to Expand At-The-Market OfferingFintel · Oct 22, 2026
- Tenon Medical Secures Approx. $2.87 Mln Through Warrant Inducement Offering; Shares Jump RTTNews · Sep 15, 2026
- 5 Biotech Stocks In Spotlight: Tenon Medical, AEON Biopharma, Silexion, Orchestra BioMed & Indaptus RTTNews · Sep 10, 2026
- Tenon Medical Completes Repayment Of Convertible Debt; Shares Surge In Pre-Market RTTNews · Sep 10, 2026
- Tenon Medical Prices $3 Mln Private Placement; Stock Down RTTNews · Aug 31, 2026
- Tenon Medical (TNON) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 20, 2026
- Tenon Medical Reports Wider Loss In Q2; Shares Fall RTTNews · Aug 20, 2026
- After-Hours Biotech Gainers: TNON, BIVI, EDSA, RNAZ, HCWB RTTNews · Aug 18, 2026
The company
Tenon Medical, Inc. is a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders. Tenon was incorporated in the State of Delaware in 2012 and currently offers two systems to treat a diseased sacroiliac joint (the 'SI Joint'). The Company has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI Joint using a single, robust titanium implant. In August 2025, the Company acquired substantially all of the assets of SiVantage, Inc. and SIMPL Medical, LLC, including the SImmetry+ SI Joint Fusion System, which treats disorders of the SI Joint through a minimally invasive lateral access solution that incorporates well-established orthopedic fusion principles.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- tenonmed.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.